- Home
- RPRX vs KEP Comparison
RPRX vs KEP Comparison
Compare RPRX & KEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RPRX | KEP |
|---|---|---|
| Founded | 1996 | 1961 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.0B | 19.8B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | RPRX | KEP |
|---|---|---|
| Price | $52.97 | $12.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $51.40 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 610.4K |
| Earning Date | 05-06-2026 | 06-16-2026 |
| Dividend Yield | 1.90% | ★ 2.82% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.67 | N/A |
| Revenue | ★ $2,378,193,000.00 | N/A |
| Revenue This Year | $38.63 | $3.18 |
| Revenue Next Year | $4.73 | $2.21 |
| P/E Ratio | $79.66 | ★ $4.54 |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $32.15 | $10.09 |
| 52 Week High | $53.47 | $23.41 |
Technical Indicators
Market Signals| Indicator | RPRX | KEP |
|---|---|---|
| Relative Strength Index (RSI) | 68.50 | 31.16 |
| Support Level | $35.35 | $12.96 |
| Resistance Level | N/A | $14.26 |
| Average True Range (ATR) | 1.08 | 0.36 |
| MACD | 0.21 | -0.20 |
| Stochastic Oscillator | 81.19 | 5.37 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About KEP Korea Electric Power Corporation
Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment. Geographically, it derives maximum revenue from Domestic operations.